Description
TIBSOVO is a prescription medicine used to treat adults with an isocitrate dehydrogenase-1 (IDH1) mutation with:
- Acute myeloid leukemia (AML):
- with newly diagnosed AML treated in combination with azacitidine or alone who are 75 years or older or who have health problems that prevent the use of certain chemotherapy treatments
- when the disease has come back or has not improved after previous treatment(s)
- Myelodysplastic syndromes (MDS):
- when the disease has come back or has not improved after previous treatment(s)
- Bile duct cancer (cholangiocarcinoma):
- with bile duct cancer that has spread and
- who have already received previous treatment(s)
Additional information
| Brand | TIBSOVO |
|---|---|
| Generic name | Ivosidenib tablets |
| Form | Oral tablets |
| Strength | 250mg |
| Packing | 60's |
| Manufacturer | Servier Pharmaceuticals LLC |
| Documents | Either PO or prescription |
| Storage | 20-25°C temperature |
Reviews
There are no reviews yet.